As the world tries to counter Omicron and bumps up booster shot campaigns, vaccine supply has once again come under discussion, as the World Economic Forum (WEF) rang the alarm bells recently of the COVID-19 vaccine manufacturing gap, and the Davos Agenda virtual event is set to discuss...More

A third shot of Sinovac’s COVID-19 vaccine given six months or more after the second shot would result in a remarkable increase in antibody levels, a new study has found, and a two-dose schedule appears to generate good immune memory. The results of the study were published on...More

China's Sinovac COVID-19 vaccine has been approved for emergency use among population aged between 3 and 17 years old, after phase-II clinic trial data suggests it is at least 98.9 percent effective in producing antibodies, a higher efficacy than in population over 18 years old. The experiment included...More

Chinese COVID-19 vaccine producers Sinopharm and Sinovac reached advance purchase agreements with the Global Alliance for Vaccines and Immunization (GAVI) to provide as many as 550 million doses of China-made vaccines for the world through the COVAX Facility, a move that would largely help the world tackle the...More

By planting Australian consultants in Papua New Guinea to manipulate local epidemic prevention policies targeting China, obstructing the authorizing of Chinese vaccines' emergency use, threatening senior officials from welcoming Chinese vaccines, Australia has been found sabotaging and disturbing Pacific Island nations' cooperation with China on vaccines and anti-virus...More

The grave epidemic situation in India, the world's largest vaccine producer, the WHO's approval of Chinese vaccines for emergency use, lingering questions on whether the US can really deliver its promise to provide vaccines to the world, all these have led to a widely acknowledged situation that China...More

Amid concerns of an immunization gap and Western media's doubts about slow inoculation, the Global Times learned that the Chinese disease control and prevention system held a nationwide online meeting on Monday to mobilize the grassroots to accelerate vaccination, with some areas vowing to vaccinate 65 percent of...More

More Chinese visa issuing authorities have offered facilitation to visa applicants who have been inoculated with Chinese COVID-19 vaccines, which is believed to be a vital step for China to promote vaccination certificates and resume exchanges while the country still has strict quarantine policies on international arrivals. Chinese...More

Zhu Tao, a member of the 13th National Committee of the Chinese People's Political Consultative Conference, proposed accelerating China's mass vaccination program to inoculate 70 percent of the population and achieve herd immunity by the end of 2021. Only when herd immunity is realized as soon as possible...More

Amid a white-hot global vaccine battle, where a row caused by the EU and the UK, and US pharmaceuticals over the delayed delivery continues to flare, another Chinese vaccine, developed by CanSino Biologics, which guarantees dual protection after only one shot, received promising preliminary signs to continue its...More

As Indonesia received its first batch of a COVID-19 vaccine from China, the promotion of pandemic containment cooperation is set to pave way for a faster economic rebound for the country, and to enhance trust and build cozier regional partnerships. Indonesia on Sunday received 1.2 million doses of...More

COVID-19 vaccine cooperation is expected to be the focus of the BRICS summit, observers said, noting that against the backdrop of COVID-19, cooperation on the vaccines has become the highlight of China's diplomacy this year, which offers a glimmer of hope for the world, and further reflects China's...More

After some cities in eastern China, where many export-driven businesses are located, showed growing demand for coronavirus vaccination, China's top regulators on drug development and epidemic prevention refuted Western media reports that China has expanded its vaccination program and has rolled out experimental vaccines to the general public,...More

A Chinese vaccine maker has begun COVID-19 vaccine clinical trials on minors to better understand the vaccine's safety and efficacy to a wider population, the Global Times learned on Tuesday. The China National Biotec Group (CNBG) of SinoPharm, China's leading vaccine producer with two inactivated vaccine candidates for...More

The COVID-19 vaccine that countries around the world are racing to acquire may not be able to provide permanent protection, and recipients who recover from the infection may become reinfected even after getting the COVID-19 vaccine, a Hong Kong virologist told the Global Times after a recent study...More